STOCK TITAN

Sanofi - SNY STOCK NEWS

Welcome to our dedicated news page for Sanofi (Ticker: SNY), a resource for investors and traders seeking the latest updates and insights on Sanofi.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Sanofi's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Sanofi's position in the market.

Rhea-AI Summary
GoodRx partners with Sanofi to offer affordable access to Lantus insulin for people with diabetes
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.56%
Tags
none
-
Rhea-AI Summary
Sanofi hosts founding ceremony of homeless futsal club 'Dream' as part of Helping Hands program
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.56%
Tags
none
-
Rhea-AI Summary
The Harris Poll reveals emotional burdens faced by people living with hemophilia and a disconnect between patients and healthcare providers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.74%
Tags
none
Rhea-AI Summary
Sanofi and Teva Pharmaceuticals announce a collaboration to co-develop and co-commercialize asset TEV '574, a therapy for ulcerative colitis and Crohn's disease. Teva will receive an upfront payment of €469 million ($500 million) and up to €940 million ($1 billion) in development and launch milestones. Initial program results expected in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.47%
Tags
none
-
Rhea-AI Summary
Sanofi collaborates with Ice-T to promote higher-dose flu vaccines for older adults
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none
-
Rhea-AI Summary
Sanofi Consumer Healthcare North America Earns B Corp Certification, Setting New Standards for Social and Environmental Impact. The company is the first large consumer healthcare company to achieve this certification, demonstrating its commitment to sustainability and social impact. The rigorous evaluation by B Lab measures the company's entire social and environmental impact, including reducing plastic packaging, greenhouse gas emissions, and achieving gender parity in senior leadership roles.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.28%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.32%
Tags
none
-
Sanofi

Nasdaq:SNY

SNY Rankings

SNY Stock Data

116.17B
1.10B
0%
9.94%
0.16%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
France
Paris

About SNY

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. Originally, the corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo